NL178421B - Aminothiazoolderivaat met ontstekinggenezende en immunoresponsregulerende werking en farmaceutisch preparaat, dat een dergelijk aminothiazoolderivaat bevat. - Google Patents

Aminothiazoolderivaat met ontstekinggenezende en immunoresponsregulerende werking en farmaceutisch preparaat, dat een dergelijk aminothiazoolderivaat bevat.

Info

Publication number
NL178421B
NL178421B NLAANVRAGE7904337,A NL7904337A NL178421B NL 178421 B NL178421 B NL 178421B NL 7904337 A NL7904337 A NL 7904337A NL 178421 B NL178421 B NL 178421B
Authority
NL
Netherlands
Prior art keywords
aminothiazole derivative
sponsulating
immune
inflammatory
effect
Prior art date
Application number
NLAANVRAGE7904337,A
Other languages
English (en)
Other versions
NL7904337A (nl
NL178421C (nl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL7904337A publication Critical patent/NL7904337A/nl
Publication of NL178421B publication Critical patent/NL178421B/nl
Application granted granted Critical
Publication of NL178421C publication Critical patent/NL178421C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
    • F16B15/00—Nails; Staples
    • F16B15/0023—Nail plates
    • F16B2015/0076—Nail plates with provisions for additional fastening means, e.g. hooks, holes for separate screws or nails, adhesive

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NLAANVRAGE7904337,A 1978-06-02 1979-06-01 Aminothiazoolderivaat met ontstekinggenezende en immunoresponsregulerende werking en farmaceutisch preparaat, dat een dergelijk aminothiazoolderivaat bevat. NL178421C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91183078A 1978-06-02 1978-06-02

Publications (3)

Publication Number Publication Date
NL7904337A NL7904337A (nl) 1979-12-04
NL178421B true NL178421B (nl) 1985-10-16
NL178421C NL178421C (nl) 1986-03-17

Family

ID=25430923

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7904337,A NL178421C (nl) 1978-06-02 1979-06-01 Aminothiazoolderivaat met ontstekinggenezende en immunoresponsregulerende werking en farmaceutisch preparaat, dat een dergelijk aminothiazoolderivaat bevat.

Country Status (36)

Country Link
JP (1) JPS5936988B2 (nl)
AR (1) AR226285A1 (nl)
AT (1) AT373248B (nl)
AU (1) AU511242B2 (nl)
BE (1) BE876732A (nl)
CA (1) CA1117949A (nl)
CH (1) CH639653A5 (nl)
CS (1) CS216927B2 (nl)
DD (1) DD144055A5 (nl)
DE (1) DE2922523C2 (nl)
DK (1) DK150068C (nl)
EG (1) EG14354A (nl)
ES (1) ES481220A1 (nl)
FI (1) FI68820C (nl)
FR (1) FR2427333A1 (nl)
GB (1) GB2022085B (nl)
GR (1) GR73142B (nl)
HK (1) HK66487A (nl)
HU (1) HU180045B (nl)
IE (1) IE48426B1 (nl)
IL (1) IL57450A (nl)
IT (1) IT1121238B (nl)
KE (1) KE3459A (nl)
LU (1) LU81349A1 (nl)
MY (1) MY8500318A (nl)
NL (1) NL178421C (nl)
NO (1) NO150760C (nl)
NZ (1) NZ190623A (nl)
PH (1) PH17020A (nl)
PL (1) PL117515B1 (nl)
PT (1) PT69718A (nl)
SE (1) SE438333B (nl)
SG (1) SG56184G (nl)
SU (1) SU843746A3 (nl)
YU (1) YU40997B (nl)
ZA (1) ZA792729B (nl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57501565A (nl) * 1980-10-24 1982-09-02
JPS57136579A (en) * 1981-01-21 1982-08-23 Mitsui Toatsu Chem Inc Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
EP0068033B1 (en) * 1981-01-08 1985-07-10 Mitsui Toatsu Kagaku Kabushiki Kaisha N-(4-phenyl-2-thiazolyl)carbamate derivatives, process for their preparation, and medicinal composition containing same
JPS57116067A (en) * 1981-01-12 1982-07-19 Sankyo Kagaku Kk Novel 8-quinolinesulfonyl derivative, its synthesis and use
US4501750A (en) * 1981-01-13 1985-02-26 Mitsui Toatsu Kaguku Kabushiki Kaisha Thiazole compounds, a process for preparing same and a pharmaceutical composition containing the thiazole compounds
WO1982002386A1 (en) * 1981-01-13 1982-07-22 Sakano Isao Aminothiazole derivatives,process for their preparation,and medicinal composition containing same
JPS57154175A (en) * 1981-03-16 1982-09-22 Mitsui Toatsu Chem Inc 2-thiazoleamine derivative, its preparation, and drug composition comprising it
DE3227329A1 (de) * 1982-07-22 1984-01-26 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2-n,n-disubstituierten aminothiazolen
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
FR2581063B1 (fr) * 1985-04-30 1987-07-17 Chauvin Blache Lab Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
JPS63152368A (ja) * 1986-06-03 1988-06-24 Sumitomo Pharmaceut Co Ltd 新規なアミノアゾ−ル誘導体およびその酸付加塩
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
ATE159622T1 (de) * 1989-08-10 1997-11-15 Commw Scient Ind Res Org Verfahren zur herstellung von einer elektrosuspension von mikropartikeln
DE69132293D1 (de) * 1991-03-07 2000-08-10 Hisamitsu Pharmaceutical Co Diphenylthiazolderivate mit antiinflammatorischer aktivität
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
CA2195847A1 (en) * 1994-07-27 1996-02-08 John J. Talley Substituted thiazoles for the treatment of inflammation
FR2754258B1 (fr) 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
US7105550B2 (en) * 2000-03-01 2006-09-12 Christopher Love 2,4-disubstituted thiazolyl derivatives
EP1423113A4 (en) * 2001-08-13 2007-04-18 Phenex Pharmaceuticals Ag NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS
WO2003027096A1 (en) * 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors
PT1471054E (pt) 2002-01-11 2009-09-23 Daiichi Sankyo Co Ltd Derivado de aminoálcool ou derivado de ácido fosfónico e composição medicinal que os contém
EP1555264A1 (en) * 2004-01-15 2005-07-20 Sireen AG Five-membered heterocyclic compounds as inhibitors of SRC family protein kinase.
KR20110136901A (ko) 2004-02-24 2011-12-21 상꾜 가부시키가이샤 아미노 알코올 화합물
KR20080019213A (ko) 2005-05-09 2008-03-03 아칠리온 파르마세우티칼스 인코포레이티드 티아졸 화합물 및 그 사용방법
ES2389062T3 (es) 2006-01-18 2012-10-22 Amgen, Inc Compuestos de tiazol como inhibidores de proteína cinasa B (PKB)
AU2008276521B2 (en) 2007-07-17 2011-11-03 Amgen Inc. Heterocyclic modulators of PKB
AU2008276512A1 (en) 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of PKB
WO2012170951A2 (en) * 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
US20120316182A1 (en) 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
US9856240B2 (en) 2011-10-19 2018-01-02 Calcimedica, Inc. Compounds that modulate intracellular calcium
CN110590785B (zh) * 2019-09-23 2021-02-02 武汉大学 一种氨基噻唑类化合物及其制备方法与抗肠道病毒71型的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458526A (en) * 1966-09-26 1969-07-29 Upjohn Co Certain 2-amino-4,5-bis(p-methoxyphenyl)thiazoles

Also Published As

Publication number Publication date
FI68820C (fi) 1985-11-11
HK66487A (en) 1987-09-25
FI68820B (fi) 1985-07-31
IT1121238B (it) 1986-03-26
GB2022085B (en) 1983-01-12
PL117515B1 (en) 1981-08-31
PT69718A (en) 1979-07-01
HU180045B (en) 1983-01-28
DD144055A5 (de) 1980-09-24
PL216030A1 (nl) 1980-03-10
YU128879A (en) 1982-10-31
IE791069L (en) 1979-12-02
EG14354A (en) 1984-06-30
GR73142B (nl) 1984-02-09
IT7923228A0 (it) 1979-06-01
NO791831L (no) 1979-12-04
NZ190623A (en) 1984-07-06
DK150068B (da) 1986-12-01
IL57450A0 (en) 1979-09-30
MY8500318A (en) 1985-12-31
NO150760B (no) 1984-09-03
CS216927B2 (en) 1982-12-31
FR2427333B1 (nl) 1983-05-20
PH17020A (en) 1984-05-11
NO150760C (no) 1984-12-12
SE7904798L (sv) 1979-12-03
BE876732A (fr) 1979-12-03
AT373248B (de) 1983-12-27
NL7904337A (nl) 1979-12-04
FI791754A (fi) 1979-11-26
DK177679A (da) 1979-12-03
JPS5936988B2 (ja) 1984-09-06
CH639653A5 (fr) 1983-11-30
ES481220A1 (es) 1980-09-01
DE2922523C2 (de) 1982-10-21
DE2922523A1 (de) 1979-12-06
FR2427333A1 (fr) 1979-12-28
ATA401679A (de) 1983-05-15
AU511242B2 (en) 1980-08-07
IE48426B1 (en) 1985-01-23
CA1117949A (en) 1982-02-09
IL57450A (en) 1982-11-30
NL178421C (nl) 1986-03-17
DK150068C (da) 1987-06-29
YU40997B (en) 1986-10-31
GB2022085A (en) 1979-12-12
SE438333B (sv) 1985-04-15
ZA792729B (en) 1981-03-25
SU843746A3 (ru) 1981-06-30
AR226285A1 (es) 1982-06-30
SG56184G (en) 1985-03-08
LU81349A1 (fr) 1979-12-07
JPS54160369A (en) 1979-12-19
KE3459A (en) 1984-10-12
AU4763479A (en) 1979-12-06

Similar Documents

Publication Publication Date Title
NL178421C (nl) Aminothiazoolderivaat met ontstekinggenezende en immunoresponsregulerende werking en farmaceutisch preparaat, dat een dergelijk aminothiazoolderivaat bevat.
NL183189C (nl) Farmaceutisch preparaat dat een met een (piperazine-1-yl)alkoxygroep gesubstitueerd carbostyrilderivaat bevat, alsmede een dergelijk carbostyrilderivaat.
NL7904013A (nl) Farmaceutische verpakking.
NL157309B (nl) Werkwijze voor het bereiden van een fenolderivaat met fungicide werking en preparaat dat dit derivaat bevat.
NL7901611A (nl) Subprojectiel dat kan worden afgeworpen vanuit een projectiel.
NL7900680A (nl) Versterker met een aantal trappen.
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
NL192111B (nl) Geneesmiddelpreparaat met anti-inflammatoire werking.
NL7410362A (nl) Chinoline-8-carbonzuurderivaten met een pesticide werking.
NL7508067A (nl) Pesticideverbindingen en preparaten.
NL191744B (nl) Farmaceutisch preparaat met werking tegen epitheelletsels.
NL7804706A (nl) Cryopomp.
NL7900647A (nl) Microbicide preparaten.
NL7510946A (nl) Herbicide-preparaten.
NL930014I2 (nl) 2,4-Dichloor-alpha(N-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat.
DZ276A1 (fr) Préparations pharmaceutiques.
IT7923177A0 (it) Articolo termo-riassestabile.
NL7902268A (nl) 2-hydroxymethylpyrazine-derivaten en een werkwijze voor de bereiding daarvan.
NL191171C (nl) Tablet met aritmie-bestrijdende werking.
NL176076C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd oleandomycinederivaat.
NL175525C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd oleandomycinederivaat.
NL7902103A (nl) Emulgeerbare preparaten.
ES242917Y (es) Mueble perfeccionado.
NL7902802A (nl) Benzimidazool- en benzimidazolidine-derivaten en farmaceutische preparaten daarvan.
NL7712100A (nl) Farmaceutische preparaten.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee